Developer docs
API playgroundTry for free, no card

Search company profiles

Balaji Amines

Full company profile

uuid003h69n

Namestring
Balaji Amines
Legal namestring
Balaji Amines Limited
Company typeenum
Public
Founded yearint
1988
Descriptiontext

Balaji Amines Limited is a publicly listed Indian specialty chemical manufacturer founded in 1988 by Ande Prathap Reddy, headquartered in Solapur, Maharashtra, with manufacturing operations across four units (three in Solapur and one in Hyderabad/Bollaram). The company produces aliphatic amines (MMA, DMA, TMA, MEA, DEA, TEA), amine derivatives (DMAHCL, DMAC, choline chloride variants, urea derivatives), specialty chemicals (NMP, Morpholine, GBL, DMF, DMC, Propylene Glycol, Propylene Carbonate, Acetonitrile), and pharma excipients (PVPK-30). It holds the world's largest DMAHCL production capacity, India's largest single-site methylamines facility at 88,000 TPA, and is the sole Indian manufacturer of GBL, NMP, and Morpholine. All process technologies are developed in-house with zero external licences, supported by a DSIR-recognised R&D centre in Hyderabad and DCS/ZLD-enabled manufacturing infrastructure.

The company generates revenue primarily through B2B direct sales of manufactured chemicals to enterprise customers in pharmaceuticals, agrochemicals, specialty chemicals, and — increasingly — the EV battery supply chain via India's first electronic-grade Dimethyl Carbonate plant commissioned in May 2025. FY26 consolidated revenue stood at ₹1,454 crore with PAT of ₹169 crore (Q4 FY26 PAT up 62% YoY, 25% EBITDA margin). Distribution operates through dedicated domestic and export sales teams serving 65+ international clients across 50+ countries, with WHO-GMP, EDQM, and REACH certifications enabling access to regulated markets in Europe, the USA, and Japan. Exports contributed 14.30% of FY26 revenue.

The company is pursuing its most consequential expansion to date through wholly-owned subsidiary Balaji Speciality Chemicals Limited (BSCL), a ₹750 crore mega project for EDA derivatives (DETA, TETA, Piperazine, AEEA, AEP), HCN, NaCN, and EDTA products, with Unit I commissioning targeted for September 2026 and Unit II for Q4 FY27. The company has 1,200+ employees and is controlled by its founders, with Reddy-family members serving as Executive Chairman, Managing Director, and Whole-time Director/CFO.

Short descriptiontext

Balaji Amines Limited is a publicly listed Indian specialty chemical manufacturer producing aliphatic amines, derivatives, specialty solvents, and pharma excipients for pharmaceutical, agrochemical, specialty chemical, and EV battery manufacturers across 50+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSolapur, India
HQ citystring
Solapur
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
aliphatic amines manufacturing, specialty chemicals production, pharma excipients supply, methylamines ethylamines, chemical intermediates exporter
Industry2 codes
1Electronic & High-Purity Specialty Chemicals
CodeIMAEABADPrimaryYes
2GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
CodeHLAGAHALPrimaryNo
NAICS code3 codes
  • Chemical Manufacturing325
  • Other Basic Organic Chemical Manufacturing32519
  • Basic Chemical Manufacturing3251
SIC code2 codes
  • Industrial Organic Chemicals2860
  • Chemicals & Allied Products2800
Product category
Specialty Chemicals
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Chemical Products Manufacturing and Sales
TypeOne Time License
Description

Balaji Amines generates revenue through the manufacture and sale of aliphatic amines (Methylamines, Ethylamines), derivatives of specialty chemicals, specialty solvents, and pharma excipients to pharmaceutical, agrochemical, and specialty chemical industries. FY26 full-year consolidated revenue stood at ₹1,454 crore.

balajiamines.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1B2B chemical product pricing - quote-based for enterprise customers
ModelOtherBilling cadenceMulti-year contract
Notes

Chemical products are sold through direct sales with pricing based on product specifications, order volume, and customer negotiations. No public pricing available.

balajiamines.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Balaji Amines manufactures and sells aliphatic amines (methylamines and ethylamines), amine derivatives, specialty chemicals (solvents like NMP, Morpholine, GBL, DMF, DMC), and pharma excipients (PVPK30) for pharmaceutical, agrochemical, specialty materials, and electric mobility industries. The company operates four manufacturing units in Solapur and Hyderabad with 2,93,600+ MTPA installed capacity, using fully proprietary in-house process technology with zero external licences. Its products serve as critical chemical intermediates and solvents for drug manufacturing, pesticides, EV battery electrolytes, and industrial applications across 50+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Full-year consolidated revenue ₹1,454 crore, PAT ₹169 crore in FY26
+3 more records
Product overview1 text field

Balaji Amines is a chemical manufacturing company specializing in aliphatic amines and specialty chemicals for critical industries including pharmaceuticals, agrochemicals, specialty materials, and electric mobility. The company operates a multi-platform manufacturing ecosystem with four units producing four product lines: (1) Amines including methylamines (MMA, DMA, TMA) and ethylamines (MEA, DEA, TEA) as core building blocks; (2) Derivatives including amine hydrochlorides (DMA HCL, TMA HCL, DEA HCL, TEA HCL, MEA HCL), Dimethyl Acetamide, Di-Methyl Urea, Choline Chloride variants, and Benzyl Tri Ethyl Ammonium Chloride; (3) Specialty Chemicals including NMP, Morpholine, GBL (all sole Indian manufacturers), DMF, Acetonitrile, Dimethyl Carbonate, Propylene Glycol, Propylene Carbonate, and other pyrrolidones; (4) Pharma Excipients including PVPK30 in multiple grades. The company has achieved import substitution for India by developing indigenous process technologies across all product lines.

Product and service19 records
1Methylamines (MMA, DMA, TMA)
CategoryAmines
Description

Aliphatic amines including Monomethylamine (MMA), Dimethylamine (DMA), and Trimethylamine (TMA) - essential building blocks for various chemical syntheses in pharmaceuticals, agrochemicals, and specialty materials.

2Ethylamines (MEA, DEA, TEA)
CategoryAmines
Description

Aliphatic amines including Monoethylamine (MEA), Diethylamine (DEA), and Triethylamine (TEA) - used as intermediates in pharmaceutical, agrochemical, and specialty chemical manufacturing.

3Dimethyl Amine Hydrochloride (DMAHCL)
CategoryDerivatives
Description

Drug intermediate used in production of Metformin, a generic diabetic drug. Balaji Amines is the largest producer of this product in the world.

4Amine Hydrochloride Derivatives (TMA HCL, DEA HCL, TEA HCL, MEA HCL)
CategoryDerivatives
Description

Aminium salt derivatives used as intermediates in pharmaceutical and specialty chemical synthesis and organic synthesis.

5Dimethyl Acetamide (DMAC)
CategoryDerivatives
Description

Polar aprotic solvent used in pharmaceutical manufacturing and petrochemical processes.

6Dimethyl Amino Ethanol (DMAE) and Diethyl Amino Ethanol (DEAE)
CategoryDerivatives
Description

Amino alcohol derivatives used in pharmaceutical intermediates and specialty chemical manufacturing.

7Choline Chloride Products
CategoryDerivatives
Description

Available in multiple forms: 60% corn cob formulation, 75% aqueous solution, and 98% powder. Used in animal feed and pharmaceutical applications.

8Benzyl Tri Ethyl Ammonium Chloride (BTEAC)
CategoryDerivatives
Description

Quaternary ammonium salt used as a phase transfer catalyst in organic synthesis.

9N-Methyl Pyrrolidone (NMP)
CategorySpecialty Chemicals
Description

High-performance polar aprotic solvent used in petrochemical processing, agrochemical formulations, and electronics manufacturing. Balaji Amines is the first and sole manufacturer in India.

10Morpholine
CategorySpecialty Chemicals
Description

Heterocyclic amine solvent used in pharmaceutical, agrochemical, and specialty chemical manufacturing. Balaji Amines is the first and sole manufacturer in India.

11Gamma-Butyrolactone (GBL)
CategorySpecialty Chemicals
Description

High-boiling solvent used in petrochemical processing and electronics manufacturing. Balaji Amines is the first and sole manufacturer in India.

12Dimethylformamide (DMF)
CategorySpecialty Chemicals
Description

Polar aprotic solvent used in pharmaceutical manufacturing and petrochemical processing. Plant commissioned at Unit III with 18,000 MTA capacity.

13Dimethyl Carbonate (DMC) - Electronic Grade
CategorySpecialty Chemicals
Description

Green solvent and intermediate used in EV battery chemistry and clean energy applications. Balaji Amines is India's first Electronic Grade DMC manufacturer.

14Propylene Glycol (Pharma Grade)
CategorySpecialty Chemicals
Description

Diol used in pharmaceutical, food, and specialty chemical applications. Pharma-grade production commissioned.

15Poly Vinyl Pyrrolidone (PVPK30)
CategoryPharma Excipients
Description

Available in IP/BP/JP grade for pharmaceutical applications and Technical grade for industrial uses. Holds Certificate of Suitability from EDQM and WHO-GMP certified production.

162-Pyrrolidone and N-Ethyl-2-Pyrrolidone (NEP)
CategorySpecialty Chemicals
Description

Cycloamide and ethylated pyrrolidone solvents used in pharmaceutical, specialty chemical applications, industrial cleaning, and specialty chemical formulations.

17Acetonitrile (ACN)
CategorySpecialty Chemicals
Description

Nitrile solvent used in pharmaceutical and electronics manufacturing applications.

18Propylene Carbonate (PC)
CategorySpecialty Chemicals
Description

Cyclic carbonate solvent used in specialty chemical and industrial applications.

19Di-Methyl Urea (DMU)
CategoryDerivatives
Description

Urea derivative used in specialty chemical applications.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Subsidiary company developing ₹750 crore mega project for next-generation specialty chemicals including EDA derivatives (DETA, TETA, Piperazine, AEEA, AEP), HCN, NaCN, EDTA and EDTA-2Na. BSCL Unit I expected to commission September 2026; BSCL Unit II expected Q4 FY27. This is the company's most consequential capex programme.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Indian basic and specialty chemicals manufacturer with phenol, acetone, and intermediates; comparable as an Indian-listed specialty platform with regulated-market customers and vertical integration across intermediates.

TypeDirect peer
Description

Indian specialty chemicals and life sciences intermediates producer (pyridines, amines, CDMO); comparable on indigenous process technology and pharma/agchem customer mix.

TypeDirect peer
Description

Indian specialty fluorochemicals and intermediates producer with regulated-market exposure; comparable as a domestic specialty platform serving pharma and agrochemical customers with proprietary process technology.

TypeDirect peer
Description

Diversified Indian specialty chemicals company serving pharma, agrochemical, and performance chemical markets; comparable on multi-product specialty platform and integrated manufacturing approach.

TypeDirect peer
Description

Indian aliphatic amines manufacturer (methylamines, ethylamines, derivatives) — the closest direct comparable to Balaji Amines given near-identical product portfolio, end-markets, and Indian market positioning.

TypeBroad incumbent
Description

Indian-listed diversified chemicals platform (soda ash, specialty, agri); comparable as an Indian specialty chemicals incumbent with broader portfolio reach though different product mix.

TypeDirect peer
Description

Large Indian specialty chemicals manufacturer serving pharma and agrochemical end-markets globally; directly comparable on scale, customer overlap, and India-based specialty chemicals platform.

TypeDirect peer
Description

Indian specialty chemicals manufacturer with strong specialty intermediates, fluorochemicals, and packaging films; comparable on B2B specialty chemicals scale, exports to regulated markets, and pharma/agchem customer base.

TypeBroad incumbent
Description

Global specialty chemicals incumbent with presence in amines, additives, and industrial chemicals; overlaps with BAL's specialty intermediates but covers a much broader portfolio across multiple chemistries.

TypeBroad incumbent
Description

Global chemical incumbent with broad amines, intermediates, and battery materials portfolios; directly competes in methylamines and DMC but operates at much larger scale with global reach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Balaji Amines

Specialty Chemicalsbalajiamines.com

Balaji Amines Limited is a publicly listed Indian specialty chemical manufacturer producing aliphatic amines, derivatives, specialty solvents, and pharma excipients for pharmaceutical, agrochemical, specialty chemical, and EV battery manufacturers across 50+ countries.

What Balaji Amines does

Balaji Amines Limited is a publicly listed Indian specialty chemical manufacturer founded in 1988 by Ande Prathap Reddy, headquartered in Solapur, Maharashtra, with manufacturing operations across four units (three in Solapur and one in Hyderabad/Bollaram). The company produces aliphatic amines (MMA, DMA, TMA, MEA, DEA, TEA), amine derivatives (DMAHCL, DMAC, choline chloride variants, urea derivatives), specialty chemicals (NMP, Morpholine, GBL, DMF, DMC, Propylene Glycol, Propylene Carbonate, Acetonitrile), and pharma excipients (PVPK-30). It holds the world's largest DMAHCL production capacity, India's largest single-site methylamines facility at 88,000 TPA, and is the sole Indian manufacturer of GBL, NMP, and Morpholine. All process technologies are developed in-house with zero external licences, supported by a DSIR-recognised R&D centre in Hyderabad and DCS/ZLD-enabled manufacturing infrastructure.

The company generates revenue primarily through B2B direct sales of manufactured chemicals to enterprise customers in pharmaceuticals, agrochemicals, specialty chemicals, and — increasingly — the EV battery supply chain via India's first electronic-grade Dimethyl Carbonate plant commissioned in May 2025. FY26 consolidated revenue stood at ₹1,454 crore with PAT of ₹169 crore (Q4 FY26 PAT up 62% YoY, 25% EBITDA margin). Distribution operates through dedicated domestic and export sales teams serving 65+ international clients across 50+ countries, with WHO-GMP, EDQM, and REACH certifications enabling access to regulated markets in Europe, the USA, and Japan. Exports contributed 14.30% of FY26 revenue.

The company is pursuing its most consequential expansion to date through wholly-owned subsidiary Balaji Speciality Chemicals Limited (BSCL), a ₹750 crore mega project for EDA derivatives (DETA, TETA, Piperazine, AEEA, AEP), HCN, NaCN, and EDTA products, with Unit I commissioning targeted for September 2026 and Unit II for Q4 FY27. The company has 1,200+ employees and is controlled by its founders, with Reddy-family members serving as Executive Chairman, Managing Director, and Whole-time Director/CFO.

Balaji Amines firmographics

Firmographics
Name
Balaji Amines
Legal name
Balaji Amines Limited
Website
https://balajiamines.com
Company type
Public
Founded year
1988
Operating status
Operating
Headcount range
101–250 employees
Short description
Balaji Amines Limited is a publicly listed Indian specialty chemical manufacturer producing aliphatic amines, derivatives, specialty solvents, and pharma excipients for pharmaceutical, agrochemical, specialty chemical, and EV battery manufacturers across 50+ countries.
Ownership category
akta.pro rank

Balaji Amines industry classification

Industry
Product category
Specialty Chemicals
NAICS
Chemical Manufacturing (325), Other Basic Organic Chemical Manufacturing (32519), Basic Chemical Manufacturing (3251)
SIC
Industrial Organic Chemicals (2860), Chemicals & Allied Products (2800)
akta.pro primary industry
Electronic & High-Purity Specialty Chemicals (IMAEABAD)
akta.pro secondary industry
GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)

Keywords

  • Aliphatic amines manufacturing
  • Specialty chemicals production
  • Pharma excipients supply
  • Methylamines ethylamines
  • Chemical intermediates exporter

Where Balaji Amines is headquartered

Location

Headquarters

HQ city
Solapur
HQ country
India
HQ region
Asia

Offices6 records

Markets served

Balaji Amines business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Chemical Products Manufacturing and Sales: Balaji Amines generates revenue through the manufacture and sale of aliphatic amines (Methylamines, Ethylamines), derivatives of specialty chemicals, specialty solvents, and pharma excipients to pharmaceutical, agrochemical, and specialty chemical industries. FY26 full-year consolidated revenue stood at ₹1,454 crore.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B chemical product pricing - quote-based for enterprise customers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Balaji Amines product offering

Product offering

Core offering

Balaji Amines manufactures and sells aliphatic amines (methylamines and ethylamines), amine derivatives, specialty chemicals (solvents like NMP, Morpholine, GBL, DMF, DMC), and pharma excipients (PVPK30) for pharmaceutical, agrochemical, specialty materials, and electric mobility industries. The company operates four manufacturing units in Solapur and Hyderabad with 2,93,600+ MTPA installed capacity, using fully proprietary in-house process technology with zero external licences. Its products serve as critical chemical intermediates and solvents for drug manufacturing, pesticides, EV battery electrolytes, and industrial applications across 50+ countries.

Product overview

Balaji Amines is a chemical manufacturing company specializing in aliphatic amines and specialty chemicals for critical industries including pharmaceuticals, agrochemicals, specialty materials, and electric mobility. The company operates a multi-platform manufacturing ecosystem with four units producing four product lines: (1) Amines including methylamines (MMA, DMA, TMA) and ethylamines (MEA, DEA, TEA) as core building blocks; (2) Derivatives including amine hydrochlorides (DMA HCL, TMA HCL, DEA HCL, TEA HCL, MEA HCL), Dimethyl Acetamide, Di-Methyl Urea, Choline Chloride variants, and Benzyl Tri Ethyl Ammonium Chloride; (3) Specialty Chemicals including NMP, Morpholine, GBL (all sole Indian manufacturers), DMF, Acetonitrile, Dimethyl Carbonate, Propylene Glycol, Propylene Carbonate, and other pyrrolidones; (4) Pharma Excipients including PVPK30 in multiple grades. The company has achieved import substitution for India by developing indigenous process technologies across all product lines.

Differentiator

Problem solved

Functional benefit

Products and services

  • Methylamines (MMA, DMA, TMA) Aliphatic amines including Monomethylamine (MMA), Dimethylamine (DMA), and Trimethylamine (TMA) - essential building blocks for various chemical syntheses in pharmaceuticals, agrochemicals, and specialty materials.
  • Ethylamines (MEA, DEA, TEA) Aliphatic amines including Monoethylamine (MEA), Diethylamine (DEA), and Triethylamine (TEA) - used as intermediates in pharmaceutical, agrochemical, and specialty chemical manufacturing.
  • Dimethyl Amine Hydrochloride (DMAHCL) Drug intermediate used in production of Metformin, a generic diabetic drug. Balaji Amines is the largest producer of this product in the world.
  • Amine Hydrochloride Derivatives (TMA HCL, DEA HCL, TEA HCL, MEA HCL) Aminium salt derivatives used as intermediates in pharmaceutical and specialty chemical synthesis and organic synthesis.
  • Dimethyl Acetamide (DMAC) Polar aprotic solvent used in pharmaceutical manufacturing and petrochemical processes.
  • Dimethyl Amino Ethanol (DMAE) and Diethyl Amino Ethanol (DEAE) Amino alcohol derivatives used in pharmaceutical intermediates and specialty chemical manufacturing.
  • Choline Chloride Products Available in multiple forms: 60% corn cob formulation, 75% aqueous solution, and 98% powder. Used in animal feed and pharmaceutical applications.
  • Benzyl Tri Ethyl Ammonium Chloride (BTEAC) Quaternary ammonium salt used as a phase transfer catalyst in organic synthesis.
  • N-Methyl Pyrrolidone (NMP) High-performance polar aprotic solvent used in petrochemical processing, agrochemical formulations, and electronics manufacturing. Balaji Amines is the first and sole manufacturer in India.
  • Morpholine Heterocyclic amine solvent used in pharmaceutical, agrochemical, and specialty chemical manufacturing. Balaji Amines is the first and sole manufacturer in India.
  • Gamma-Butyrolactone (GBL) High-boiling solvent used in petrochemical processing and electronics manufacturing. Balaji Amines is the first and sole manufacturer in India.
  • Dimethylformamide (DMF) Polar aprotic solvent used in pharmaceutical manufacturing and petrochemical processing. Plant commissioned at Unit III with 18,000 MTA capacity.
  • Dimethyl Carbonate (DMC) - Electronic Grade Green solvent and intermediate used in EV battery chemistry and clean energy applications. Balaji Amines is India's first Electronic Grade DMC manufacturer.
  • Propylene Glycol (Pharma Grade) Diol used in pharmaceutical, food, and specialty chemical applications. Pharma-grade production commissioned.
  • Poly Vinyl Pyrrolidone (PVPK30) Available in IP/BP/JP grade for pharmaceutical applications and Technical grade for industrial uses. Holds Certificate of Suitability from EDQM and WHO-GMP certified production.
  • 2-Pyrrolidone and N-Ethyl-2-Pyrrolidone (NEP) Cycloamide and ethylated pyrrolidone solvents used in pharmaceutical, specialty chemical applications, industrial cleaning, and specialty chemical formulations.
  • Acetonitrile (ACN) Nitrile solvent used in pharmaceutical and electronics manufacturing applications.
  • Propylene Carbonate (PC) Cyclic carbonate solvent used in specialty chemical and industrial applications.
  • Di-Methyl Urea (DMU) Urea derivative used in specialty chemical applications.

Quantifiable outcome

  • Full-year consolidated revenue ₹1,454 crore, PAT ₹169 crore in FY26
  • +3 more outcomes

Companies that use Balaji Amines

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Balaji Amines technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Balaji Amines partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Balaji Speciality Chemicals Limited (BSCL)coreStrategic or Co-development PartnerSubsidiary company developing ₹750 crore mega project for next-generation specialty chemicals including EDA derivatives (DETA, TETA, Piperazine, AEEA, AEP), HCN, NaCN, EDTA and EDTA-2Na. BSCL Unit I expected to commission September 2026; BSCL Unit II expected Q4 FY27. This is the company's most consequential capex programme.

Scale indicators15 records

Recent moves6 records

Expansion highlights5 records

Balaji Amines competitors and assessment

Company assessment

Direct peers

  • Deepak Nitrite: Indian basic and specialty chemicals manufacturer with phenol, acetone, and intermediates; comparable as an Indian-listed specialty platform with regulated-market customers and vertical integration across intermediates.
  • Jubilant Ingrevia: Indian specialty chemicals and life sciences intermediates producer (pyridines, amines, CDMO); comparable on indigenous process technology and pharma/agchem customer mix.
  • Navin Fluorine International: Indian specialty fluorochemicals and intermediates producer with regulated-market exposure; comparable as a domestic specialty platform serving pharma and agrochemical customers with proprietary process technology.
  • Atul Limited: Diversified Indian specialty chemicals company serving pharma, agrochemical, and performance chemical markets; comparable on multi-product specialty platform and integrated manufacturing approach.
  • Alkyl Amines Chemicals: Indian aliphatic amines manufacturer (methylamines, ethylamines, derivatives) — the closest direct comparable to Balaji Amines given near-identical product portfolio, end-markets, and Indian market positioning.
  • Aarti Industries: Large Indian specialty chemicals manufacturer serving pharma and agrochemical end-markets globally; directly comparable on scale, customer overlap, and India-based specialty chemicals platform.
  • SRF Limited: Indian specialty chemicals manufacturer with strong specialty intermediates, fluorochemicals, and packaging films; comparable on B2B specialty chemicals scale, exports to regulated markets, and pharma/agchem customer base.

Broad incumbents

  • Tata Chemicals: Indian-listed diversified chemicals platform (soda ash, specialty, agri); comparable as an Indian specialty chemicals incumbent with broader portfolio reach though different product mix.
  • Lanxess: Global specialty chemicals incumbent with presence in amines, additives, and industrial chemicals; overlaps with BAL's specialty intermediates but covers a much broader portfolio across multiple chemistries.
  • BASF: Global chemical incumbent with broad amines, intermediates, and battery materials portfolios; directly competes in methylamines and DMC but operates at much larger scale with global reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Balaji Amines social profiles

Digital presence

Balaji Amines compliance and trust

Trust signal

Compliance7 records

Balaji Amines financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Balaji Amines leadership team

Management profile

Number of profiles

Profiles15 records

Balaji Amines subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Balaji Amines funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Balaji Amines M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Balaji Amines

What does Balaji Amines do?

Balaji Amines manufactures and sells aliphatic amines (methylamines and ethylamines), amine derivatives, specialty chemicals (solvents like NMP, Morpholine, GBL, DMF, DMC), and pharma excipients (PVPK30) for pharmaceutical, agrochemical, specialty materials, and electric mobility industries. The company operates four manufacturing units in Solapur and Hyderabad with 2,93,600+ MTPA installed capacity, using fully proprietary in-house process technology with zero external licences. Its products serve as critical chemical intermediates and solvents for drug manufacturing, pesticides, EV battery electrolytes, and industrial applications across 50+ countries.

Is Balaji Amines a public or private company?

Balaji Amines is a public company. It is classified as public and is currently operating.

When was Balaji Amines founded?

Balaji Amines was founded in 1988. It employs 101 to 250 people.

Where is Balaji Amines based?

Balaji Amines is headquartered in Solapur, India, in the Asia region.

How does Balaji Amines make money?

One revenue line is on record: chemical Products Manufacturing and Sales.

Who are Balaji Amines's main competitors?

Direct peers on record are Deepak Nitrite, Jubilant Ingrevia, Navin Fluorine International, Atul Limited, Alkyl Amines Chemicals, Aarti Industries and SRF Limited. Broad incumbents are Tata Chemicals, Lanxess and BASF.

Does Balaji Amines have an API?

No public API is recorded for Balaji Amines.

What industry is Balaji Amines in?

Balaji Amines's product category is Specialty Chemicals. Its primary akta.pro industry code is IMAEABAD, Electronic & High-Purity Specialty Chemicals, with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 325 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Times of IndiaSpecialty chemical stocks rally as earnings hopes lift trading volumesSpecialty chemical stocks rallied on Tuesday, led by Balaji Amines and Alkyl Amines Chemicals, as investors bet on improving earnings. Balaji Amines hit a 20% circuit, and Equirus Capital's sector note cites recovering margins and volume growth, though capacity utilisation and global risks remain key monitors.Business StandardSpecialty chemicals: Alkyl, Balaji Amines zoom up to 20% on huge volumeBalaji Amines and Alkyl Amines Chemicals shares rose 20% on the BSE on Tuesday amid heavy volume, with Balaji Amines locked at the 20% upper circuit. The Indian specialty chemicals sector is showing early recovery, with EBITDA margins at 15.6% in FY26 and revenue growth of 22% in Q1FY27. The market is projected to grow from $36 billion in 2025 to $61 billion by 2030.Business Todayकेमिकल शेयरों में आज तूफानी तेजी! Balaji Amines 20% चढ़ा; Deepak Nitrite, Aarti Industries भी चढ़े; जानिए वजह - why Chemical Stocks Rally Balaji Amines Surges 20 percent Deepak Nitrite and Aarti Industries Gain Ahead of Q2 Results -Chemical stocks rallied on Tuesday, with Balaji Amines surging 20% to 2,349.30 rupees, Deepak Nitrite up 3% to 1,542 rupees, and Aarti Industries gaining 2.93% to 484.65 rupees. Elara Securities expects better product realization but limited quarterly improvement due to raw material cost pressures.Business StandardBalaji Amines commences Acetonitrile production at Solapur plantBalaji Amines commenced commercial production of acetonitrile at its Solapur plant, enhancing installed capacity to 1,440 tonnes per month. The company reported a 97.21% increase in net profit to Rs 74.94 crore in Q1 FY27, with revenue up 27.23% to Rs 455.93 crore.IndianchemicalnewsBalaji Amines starts commercial production at enhanced acetonitrile plantBalaji Amines Limited began commercial production at its acetonitrile plant in Solapur on September 24, 2026. The facility now operates with an enhanced installed capacity of 1,440 tonnes per month, part of Unit III operations. The upgrade strengthens the company's position in the specialty chemicals sector.AInvestBalaji Amines' Rating 'Withdrawal' Is a Non-Event. The 45x Multiple Is the Real NewsIndia Ratings withdrew Balaji Amines' bank-loan rating after the company cleared its dues, citing no outstanding obligations. The company holds about ₹300 crore net cash and is spending ₹344 crore on capex, with FY26 net income up 97% to ₹750 million. The stock trades at a 45x multiple, betting on monetization of new capacity.Simply Wall StWhen Should You Buy Balaji Amines Limited (NSE:BALAMINES)?Balaji Amines shares are trading at a 40.72x price-to-earnings ratio, well above the industry average of 20.65x, despite a recent price surge. The company expects profit growth of 46% over the next two years, but the elevated valuation suggests limited upside from mispricing.Business News TodayTrade Spotlight: How should you trade IFCI, Balaji Amines, ACME Solar Holdings, Indraprastha Gas, Tata Communications, and others on September 7?Technical analysts on September 7 recommend buying IFCI, Balaji Amines, ACME Solar Holdings, Indraprastha Gas, and Reliance Industries, while selling Sun Pharmaceutical. Targets and stop-losses are given for each stock, with IFCI's breakout above Rs 90-93 and Balaji Amines' flag breakout at Rs 2,455 cited.ScanXBalaji Amines hosts analyst meet and plant visit on August 25Balaji Amines Limited has scheduled an analyst meet and plant visit for August 25, 2026, at its Solapur facility in Maharashtra. The company notified the BSE and NSE that discussions will be strictly limited to publicly available information, with no unpublished price-sensitive information shared. This event is part of a series of investor interactions aimed at providing operational transparency to analysts and institutional investors.Business News TodayBalaji Amines Standalone June 2026 Net Sales at Rs 422.74 crore, up 32.36% Y-o-Y- Moneycontrol.comBalaji Amines reported standalone financial results for Q2 June 2026 with net sales of Rs 422.74 crore, representing a 32.36% year-on-year increase from Rs 319.38 crore in June 2025. The company posted net profit of Rs 72.14 crore, surging 81.26% from Rs 39.80 crore in the same period last year, while EBITDA rose 72% to Rs 109.63 crore. EPS improved to Rs 22.27 compared to Rs 12.28 year-on-year, reflecting strong operational performance.